Quantcast

Latest Argos Stories

2010-02-05 08:00:00

- High-resolution photos available upon request - PALM BEACH, FL, Feb. 5 /PRNewswire/ - Twenty-six cheerleaders representing the AFC and the NFC in the Pro Bowl toured Miami's glamorous waterways aboard the luxurious 92-foot Argos Gulfstream yacht ("Argos G92") in the days before Sunday's big game. The cheerleaders and their friends soaked in views of the city and explored the floating mansion as more than 50 guests gathered under sunny skies, hosted by international yacht builder Tricon...

2009-10-23 11:09:00

MEDELLIN, Colombia, Oct. 23 /PRNewswire-FirstCall/ -- On a consolidated basis, Cementos Argos (OTC Bulletin Board: CMTOY) posted operating revenues of COP $2.7 billion (US$ 1,216 million), which were 4% lower than those for the same period last year. The Company obtained savings of 7% through its cost and expense reduction program, which produced a 37% increase in operating profits. EBITDA rose by 15% to COP$ 516 billion (US$ 234 million). On the other hand, consolidated EBITDA rose...

2009-07-30 10:07:23

Cinelatino has announced it has entered into a partnership with Mexico's Argos Comunicacion to produce original television movies exclusively for Cinelatino. Cinelatino is a popular Spanish-language movie channel in the United States. Argos Comunicacion is a successful Mexican independent production company. Argos has a track record for producing the highest-quality feature films and television product and we are confident these movies will deliver the great quality and entertainment value...

2008-12-23 18:07:00

MEDILLIN, Colombia, Dec. 23 /PRNewswire/ -- Today, Cementos ARGOS S.A. reached an agreement for the sale of its coal and logistic assets with Companhia Vale do Rio Doce (Vale), for an estimated amount of $373 million, which will be paid as follow: $300 million upfront at the closing date and $73 million estimated by ARGOS depending on the result of a geological study of mineral resources that will be developed during the next two years in one of the areas subject to the transaction. The...

2008-09-11 09:00:48

Argos Therapeutics has initiated a Phase IIa trial of its AGS-003 therapy, in combination with sunitinib, for the treatment of newly diagnosed advanced renal cell carcinoma. Approximately 50 subjects with advanced renal cell carcinoma (RCC) will be enrolled in the Phase IIa trial. The study will be conducted at up to 15 sites in North America. The primary study objective is to evaluate clinical activity of AGS-003 in combination with sunitinib, as defined by RECIST criteria. Secondary...

2008-09-10 09:00:09

Argos Therapeutics today announced the initiation of a Phase 2a trial of its AGS-003 therapy, in combination with sunitinib, for the treatment of newly diagnosed advanced renal cell carcinoma (RCC). AGS-003 is a product of the Company's Arcelis(TM) technology, which is an immunotherapy platform for creating personalized, RNA-loaded, dendritic cell-based therapies perfectly matched to each patient's unique tumor burden. In vitro and animal model studies of the impact of sunitinib on the...

2008-08-06 12:00:58

Argos Therapeutics has reported positive immune response data from a Phase I clinical trial of AGS-004 in HIV-infected adults in combination with antiretroviral therapy. AGS-004 achieved the trial's primary endpoint of induction of T cell response to patient-specific HIV antigens. AGS-004 is a personalized HIV immunotherapy generated by the company's Arcelis technology. According to the company, Arcelis is an immunotherapy platform for creating personalized, RNA-loaded dendritic...

2008-08-05 09:01:31

Argos Therapeutics today announced the presentation of positive immune response data from a Phase 1 clinical trial of AGS-004 in HIV-infected adults in combination with antiretroviral therapy (ART). AGS-004 achieved the trial's primary endpoint of induction of T cell response to patient-specific HIV antigens. AGS-004 is a personalized HIV immunotherapy generated by the Company's Arcelis(TM) technology. Arcelis is an immunotherapy platform for creating personalized, RNA-loaded dendritic...

2008-07-14 09:01:12

Argos Therapeutics today announced that Tamara Monesmith, Director of Manufacturing and Process Development, will present details on the Company's automated approach to manufacturing personalized dendritic cell immunotherapies. The Company's advanced manufacturing process is complementary to its Arcelis(TM) technology, a proprietary platform for creating personalized immunotherapies for HIV, other infectious diseases, and cancer. The presentation will take place at the IBC Next Generation...


Latest Argos Reference Libraries

10_882dd38af9cdeb8842ce7e31c378113c2
2004-10-19 04:45:44

Perseus Constellation -- Location: Northern Hemisphere; Coordinates: Right Ascension: 03h; Declination: +45; Source: Greek Mythology Perseus was the son of the Greek god Zeus and the mortal princess Danae. Perseus' grandfather, Acrisius, the king of Argos, was warned by an oracle that he would be killed by his grandson. Acrisius locked his daughter Danae in a dungeon to prevent her bearing a child. Zeus found a way into her dungeon disguised as a shower of gold. When the child Perseus...

More Articles (1 articles) »
Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related